True Wealth Design LLC bought a new stake in Exelixis, Inc. (NASDAQ:EXEL – Free Report) in the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor bought 34,516 shares of the biotechnology company’s stock, valued at approximately $828,000. Other hedge funds have also […]
Exelixis (NASDAQ:EXEL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday. Other equities analysts have also issued reports about the company. Royal Bank of Canada upped their target price on Exelixis from $26.00 to $28.00 and gave the […]
Exelixis (NASDAQ:EXEL – Get Free Report) was downgraded by analysts at StockNews.com from a “strong-buy” rating to a “buy” rating in a note issued to investors on Tuesday. Other equities analysts have also issued reports about the company. Royal Bank of Canada upped their target price on Exelixis from $26.00 to $28.00 and gave the […]
Exelixis, Inc. (NASDAQ:EXEL) Director David Edward Johnson Acquires 225,000 Shares of Stock themarketsdaily.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from themarketsdaily.com Daily Mail and Mail on Sunday newspapers.
Exelixis (NASDAQ:EXEL) Shares Gap Up on Insider Buying Activity modernreaders.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from modernreaders.com Daily Mail and Mail on Sunday newspapers.
Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) has been given a consensus recommendation of “Moderate Buy” by the seventeen analysts that are covering the stock, Marketbeat Ratings reports. Seven research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company. The average 1 year price target […]
Shares of Exelixis, Inc. (NASDAQ:EXEL – Get Free Report) have been given an average rating of “Moderate Buy” by the sixteen research firms that are presently covering the company, MarketBeat Ratings reports. Six research analysts have rated the stock with a hold recommendation and ten have assigned a buy recommendation to the company. The average […]
Exelixis (NASDAQ:EXEL – Free Report) had its price objective increased by TD Cowen from $25.00 to $27.00 in a report issued on Wednesday, Benzinga reports. The firm currently has a buy rating on the biotechnology company’s stock. A number of other brokerages also recently weighed in on EXEL. TheStreet raised shares of Exelixis from a […]
Exelixis (NASDAQ:EXEL) Issues Quarterly Earnings Results, Misses Expectations By $0.16 EPS kopsource.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from kopsource.com Daily Mail and Mail on Sunday newspapers.
Exelixis (NASDAQ:EXEL) Issues Earnings Results theenterpriseleader.com - get the latest breaking news, showbiz & celebrity photos, sport news & rumours, viral videos and top stories from theenterpriseleader.com Daily Mail and Mail on Sunday newspapers.